共 14 条
[1]
Role of oxidized low density lipoprotein in atherogenesis. Witztum JL,Steinberg D. The Journal of Clinical Investigation . 1991
[2]
Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Wu R,Huang YH,Elinder LS,et al. Arteriosclerosis and Thrombosis . 1998
[3]
Studies on epitopes on low density lipoprotein modified by 4-hydroxynonenal. Chen Q,Esterbauer H,Jurgens G,et al. Biochemical Journal . 1992
[4]
Crossreaction between antiboddies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Vaarala O,Alfthan G,Jauhiainen M,et al. The Lancet . 1993
[5]
Autoantibody against oxidised LDL and progression of caotid atherosclerosis. Salmon JT,Yla-Herttuala S,Yamamoto R,et al. The Lancet . 1992
[6]
Are immunological mechanisms relevant for the development of atherosclerosis. Witzturm JL,Palinski W. Clinical Immunology . 1999
[7]
Autoantibody against oxidized low density lipoprotein: a review of clinical findings and assay methodology. Craig WY. Journal of Clinical Laboratory Analysis . 1995
[8]
Byond cholesterol: Modifications of lowdensity lipoprotein that incerease its atherogenicity. Steinberg D,Parthasarathy S,Carew TE,et al. The New England Journal of Medicine . 1989
[9]
Activation of human monocyte-derived macrophages by immune complexes containing low-density lipoprotein. Virella G,Munoz JF,Galbraith GMP,et al. Clinical Immunology and Immunopathology . 1995
[10]
Autoantibody against oxidized low density lipoprotein and cardiolipin in patients with coronary heart disease. Erkkila AT,Narvanen O,Lehto S,et al. Arteriosclerosis and Thrombosis . 2000